Proposed withdrawal of bipolar disorder treatment revoked
The manufacturer of first-line bipolar disorder treatment Priadel (lithium carbonate) has agreed to continue supplying the NHS with the drug, after negotiating new prices with the Department of Health and Social Care (DHSC).
